Honggang Bi, PhD

  • General Manager, China 

Dr. Honggang Bi is a world-renowned bioanalytical scientist with more than 15 years of experience in pharmaceutical research and development. His scientific achievement can be evidenced by more than 30 research publications and various presentations at scientific conferences. He reports directly to the Chief Executive Officer.

Dr. Bi joined Covance in 2007 from Frontage Laboratories, where as Chief Executive Officer, he led the organization with three-fold revenue and earnings growth in two years, expanding the company’s client base and service offerings with quality work and expertise. Prior to Frontage, Dr. Bi headed operations for Pfizer’s department of Pharmacokinetics, Dynamics and Metabolism, served as director of Bioanalytical Chemistry and Metabolism at Parke-Davis Pharmaceutical Research, and held positions of increasing responsibility in drug analysis, metabolism, and pharmacokinetics research at SmithKline Beecham Pharmaceuticals.

Dr. Bi received his PhD in chemistry and drug metabolism from McGill University in Montreal, Canada. He also holds a Master of Science degree in pharmaceutical analysis from the Institute of Materia Medica at the Chinese Academy of Medical Sciences in Beijing, and a bachelor of pharmacy degree from the School of Pharmacy at Zhejiang University in Hangzhou, Peoples Republic of China.